Literature DB >> 18634034

Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.

Zhibin Hu1, Jie Liang, Zhanwei Wang, Tian Tian, Xiaoyi Zhou, Jiaping Chen, Ruifen Miao, Yan Wang, Xinru Wang, Hongbing Shen.   

Abstract

Small, noncoding RNA molecules, called microRNAs (miRNAs), are thought to function as either tumor suppressors or oncogenes. Common single-nucleotide polymorphisms (SNPs) in miRNAs may change their property through altering miRNA expression and/or maturation, and thus they may have an effect on thousands of target mRNAs, resulting in diverse functional consequences. However, it remains largely unknown whether miRNA SNPs may alter cancer susceptibility. We evaluated the associations of selected four SNPs (rs2910164, rs2292832, rs11614913, and rs3746444) in pre-miRNAs (hsa-mir-146a, hsa-mir-149, hsa-mir-196a2, and hsa-mir-499) with breast cancer risk in a case-control study of 1,009 breast cancer cases and 1,093 cancer-free controls in a population of Chinese women and we found that hsa-mir-196a2 rs11614913:T>C and hsa-mir-499 rs3746444:A>G variant genotypes were associated with significantly increased risks of breast cancer (odds ratio [OR], 1.23; 95% confidence interval [CI], 1.02-1.48 for rs11614913:T>C; and OR, 1.25; 95% CI, 1.02-1.51 for rs3746444:A>G in a dominant genetic model) in a dose-effect manner (P for trend was 0.010 and 0.037, respectively). These findings suggest, for the first time, that common SNPs in miRNAs may contribute to breast cancer susceptibility. Further functional characterization of miRNA SNPs and their influences on target mRNAs may provide underlying mechanisms for the observed associations and disease etiology. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18634034     DOI: 10.1002/humu.20837

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  171 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

2.  Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease.

Authors:  Hong Zhi; Lina Wang; Genshan Ma; Xingzhou Ye; Xiaojin Yu; Yi Zhu; Yu Zhang; Jiaju Zhang; Bei Wang
Journal:  Clin Res Cardiol       Date:  2011-12-11       Impact factor: 5.460

3.  Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies.

Authors:  Jun Wang; Jingwang Bi; Xin Liu; Kainan Li; Jianshi Di; Baocheng Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

4.  Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls.

Authors:  Jian Zhang; Yan-Fei Liu; Yu Gan
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

5.  Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population.

Authors:  Ying Zeng; Qing-Min Sun; Nan-Nan Liu; Guang-Hui Dong; Jie Chen; Li Yang; Bin Wang
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

6.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

Review 7.  Cross talk between microRNA and coding cancer genes.

Authors:  Tanja Kunej; Irena Godnic; Simon Horvat; Minja Zorc; George A Calin
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

8.  A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

Authors:  Elena Ratner; Lingeng Lu; Marta Boeke; Rachel Barnett; Sunitha Nallur; Lena J Chin; Cory Pelletier; Rachel Blitzblau; Renata Tassi; Trupti Paranjape; Pei Hui; Andrew K Godwin; Herbert Yu; Harvey Risch; Thomas Rutherford; Peter Schwartz; Alessandro Santin; Ellen Matloff; Daniel Zelterman; Frank J Slack; Joanne B Weidhaas
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

9.  Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.

Authors:  Brock C Christensen; Michele Avissar-Whiting; Lauren G Ouellet; Rondi A Butler; Heather H Nelson; Michael D McClean; Carmen J Marsit; Karl T Kelsey
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

10.  Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Bing Zhou; Liang-Peng Dong; Xiao-Yue Jing; Jin-Song Li; Shu-Juan Yang; Jun-Ping Wang; Long-Feng Zhao
Journal:  Tumour Biol       Date:  2014-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.